Julie Papanek Grant, Director at Day One Biopharmaceuticals, Inc. (DAWN), sold 50,000 shares at $20.36 ($1.0M) on 2023-01-03, disclosed to the SEC on 2023-01-04.
Open-market sale of $1.0M DAWN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.36 | 17,390 | $354K | 34.3% |
| 2 | $20.36 | 17,390 | $354K | 34.3% |
| 3 | $21.31 | 7,610 | $162K | 15.7% |
| 4 | $21.31 | 7,610 | $162K | 15.7% |
| Total | $20.65 avg | 50,000 | $1.0M | 100% |
| Filing → |
| DAWN | SELL | 2022-12-12 | $192K | — | Filing → |
| DAWN | SELL | 2022-12-05 | $320K | — | Filing → |
| DAWN | SELL | 2022-11-03 | $300K | — | Filing → |